100 likes | 187 Views
Region 4 Genetics Collaborative. Long-term Follow-up Projects. Inborn Errors of Metabolism Information System (IBEM-IS). Project Lead Susan Berry, MD. IBEM-IS. Goal To gather uniform data and asses clinical practice differences to learn which treatment strategies are most effective
E N D
Region 4 Genetics Collaborative Long-term Follow-up Projects
Inborn Errors of Metabolism Information System (IBEM-IS) Project Lead Susan Berry, MD
IBEM-IS • Goal • To gather uniform data and asses clinical practice differences to learn which treatment strategies are most effective • Product • Disease registry to track treatment and outcomes of patients
Current Scope • Elements defined for 33 genetic conditions • All fatty acid oxidation disorders • Maple Syrup Urine Disease and Tyrosenemia • C3; C5OH disorders; and GA-1 • Biotinidase and Glactosemia
Clinics Participating • Project Participation • 9 Region 4 clinics • 2 Heartland clinics • Pending IRB approval • 1 Region 4 Clinic • 1 Heartland Clinic
Cases Entered 7 2 2 4 87 14 7 5 11 7 2 Total subjects = 135 • Carnitine Uptake Disorder (CUD) • Carnitine palmitoyltransferase (CPT 1 & 2) • isobutyryl-CoA dehydrogenase (IBD) deficiency • Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) • Medium-chain acyl-coenzyme dehydrogenase (MCAD) • Maple Syrup Urine Disease – • Short chain acyl CoA dehydrogenase deficiency (SCAD) – • Tri-functional protein deficiency (TFP) • Very-long chain acyl-CoAdehydrogenase deficiency (VLCAD) • Carnitine Update Disorder (CUD) • Carnitine Palmitoyl transferase Deficiency 1 / 2 (CPT)
New Developments Companion surveys under development: • Dialysis • Imaging • Pregnancy • Transplant
Congenital Adrenal Hyperplasia Long-term Follow-up Project Lead Kyriakie Sarafoglou, M.D.
Benefits • Provide valuable information on a broader scale than can be obtained at a single institution • Catalyst to create collaborative research projects • Examine effect of “stigma” on CAH patients • Better methods of monitoring disease control • Improved understanding of the disease course and ways to improve outcomes
Current Status • CAH surveys complete and entered into DocSite platform • DSD surveys drafted • Urogenital surveys drafted